Modeling the Prader-Willi Syndrome Associated Growth Phases in Snord116 KO Mice
Preprint
- 29 September 2026
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Prader–Willi syndrome (PWS) is a neurodevelopmental disorder characterized by distinctive developmental transition from neonatal hypotonia and poor feeding to pro-gressive weight gain and, later, hyperphagia and obesity. The paternally expressed SNORD116 cluster is critical for postnatal growth, but how its deficiency shapes this progression remains unclear. Here, we analyzed day-over-day growth rates in 351 mice carrying Snord116 deletion or altered Snord116 dosage, including wild-type littermates, across both sexes and two genetic backgrounds. Snord116 expression increased markedly during early brain development. Snord116-deficient mice exhibited a distinct three-stage growth trajectory: impaired growth until approximately P16, normalization between P17 and P21, followed by transient accelerated weight gain until approximately P30. Alt-hough growth rates subsequently normalized, the accumulated deficit was not fully compensated, and adult Snord116KO mice remained smaller than wild-type controls. These developmental transitions broadly parallel early nutritional phases of human PWS, although mice did not progress to persistent obesity-associated growth. Reactivation of the maternal Snord116 cluster partially rescued the growth phenotype, whereas activation of both parental alleles produced a modest growth advantage, most evident in males. These findings identify early postnatal development as a critical window of Snord116-dependent growth regulation and provide a framework for investigating mechanisms underlying PWS progression.Keywords
All Related Versions
This publication has 48 references indexed in Scilit:
- Loss of Snord115 mitigates Snord116-driven sleep abnormalities in mouse models of Prader-Willi syndromeNeurobiology of Disease, 2026
- The paradox of Prader-Willi syndrome revisited: Making sense of the phenotypeEBioMedicine, 2022
- Obesity in Prader–Willi syndrome: physiopathological mechanisms, nutritional and pharmacological approachesJournal of Endocrinological Investigation, 2021
- Box C/D small nucleolarRNAgenes and the Prader‐Willi syndrome: a complex interplayWIREs RNA, 2017
- Highly restricted deletion of the SNORD116 region is implicated in Prader–Willi SyndromeEuropean Journal of Human Genetics, 2014
- Prader-Willi syndromeGenetics in Medicine, 2012
- Nutritional phases in Prader–Willi syndromeAmerican Journal of Medical Genetics Part A, 2011
- Paternally inherited microdeletion at 15q11.2 confirms a significant role for the SNORD116 C/D box snoRNA cluster in Prader–Willi syndromeEuropean Journal of Human Genetics, 2010
- Dynamic developmental regulation of the large non-coding RNA associated with the mouse 7C imprinted chromosomal regionDevelopmental Biology, 2005
- Exclusion of the C/D box snoRNA gene cluster HBII-52 from a major role in Prader?Willi syndromeHuman Genetics, 2004